Failure of Phyllanthus amarus to Eradicate Hepatitis B Surface Antigen from Asymptomatic Chronic Hepatitis B Virus Carriers: One-Year Follow-up Study
نویسندگان
چکیده
We designed a randomized controlled trial to study the effectiveness ofPhyllanthus amarus in the eradication of the chronic carriage of hepatitis B virus (HBV). One hundred and sixteen asymptomatic carriers who were positive for hepatjtis B surface antigen (HBsAg) on two occasions at least six months apart were admitted to the study. They were randomly allocated to receive P. amarus (1,200 mg/day) or placebo orally for 30 days. Both drug and placebo were contained in identical capsules which were taken three times daily. Blood for hematological, biochemical, HBsAg and HBeAg determination was taken at regular intervals. At days 15, 30 and 60, HBsAg was detectable in every case of both groups. At days 180 and 360 it was still detectable in 48 of 49 and 41 of 42; and in 39 of 40 and 36 of 37 patients given P. amarus or placebo respectively. HBeAg level was significantly decreased at day 30 in only P. amarus group (p < 0.01) but not at day 60. Most subjects of both groups felt that their clinical status had not changed. No toxic effect was observed or detected. We conclude that P. amarus available in Thailand may not be as effective as it has been reported in the eradication of the chronic carrier state ofHBV. "" , L1€J.JlJEJ allu1vmmlmtJ1liaumtlfhll~iIl1::m'niluft1't'1::iffl~~'IJfl~ 11~a~'lJt)ntatJ UluNtJ1'illfllaMVl . " " ..et U'.c::I r! r!.4 r!.c:.. fl1l1 aa11flll ft.tJ. *, '1111011 Vl1::fJaall'!J101 1'f1.11.*, ftltl11 l't'lllflU1~'Yt1!lVl 1'f1.11.**, QJ r! _I ** ..et .c:.. *** *** OJ.c::I r! a *** Iflllfl11allU::ftUIi 1J1.~. , ft1101 ftl~'If 1'f1.11. , tJ'YtJlll1Vl1::na 1'f1.11. , 'fIflUU laUU1fl ft.tJ. , . . " OJ .c:..~ QJ r! .c::I QJ ~ 1llJlU1 (J'fIlillVl 1'f1.tJ.**, 'fIflUmU llU'fIUU~U~ ft.tJ. t A A..l' A fS' <IS f"or::::u::t. t *Wl"1l11"lf1 "fl~~L"lfeJ 1l1m"lf1m~"~1~~" tLL~,"n1i,"1mdLG'leJ~ flnl.::LL"'fY111~1~~"~dd1"lfWlI11J1G'l A Cl.o' f" A Cl.o' oI':llA Cl.o' _ f" .ell _ A **1l1m"lf1Lll~"lfWt]m~1~~" LLG'l::1l1m"lf1Lll~1Wil\l,1I flnl.::Lll~"lf~1~~" :IJ'V\11'Yl1l1G'l1l:IJ'V\~G'l, ** *flnl.::L'YlfliiflmdLLW'Yl6 :IJ'V\11'Yl1l1ill:IJ~~G'l m"L'YlW"l • J ... "" T 2534; 8:1-6. ?11lf711F1!i1!i1L'lf€JLm~lJ1r;n'Uv"'lfW flOl::"11lU1~fin'Y1U1::a'fli"a'IJfl~allU1ft1anlVlitJ(Phyllanthus amarus) lum1fhll~ " . " QJQJQJ ~I XU 1 .c::Il "' ... l<Cl..c::I cf..e:t .d iIl1::m111JUft1't'1::11fl1~'IJfl-3 1~aVltJflntatJ tJ U"tJ1'illfl a't'lVlua::lla'IJiIlftU'IJ-3U~-3~ 116 11£1 CJI-3 " . "H"amnlUm1'f1~afltJ't'I1 HBsAg 'U:U~llflUn"flU 2 flf-3 ";l~nu 6 l~flU ft1't'1::m,hm~1tJm1 alll'111~~tJallu1ft~anlmtJ 't'I;mi'lVlla';-3tJ'j11lflU1uutl'uCJlamijflunu allu1ft1anlmtJ1~~tJm1 CIi CIi 'U q 'II 'II q 'II *Departments ofMedicine and tTransfusion Medicine, Faculty ofMedicine Siriraj Hospital, **Department ofPharmacognosy, Faculty of Pharmacy and ***Faculty ofMedical Technology, Mahidol University, Thailand. .., 2 "'.PI. -"'.PI. 2534
منابع مشابه
A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen.
BACKGROUND There have been conflicting data in literature about the value of Phyllanthus amarus in treating hepatitis B virus-related disorders. AIM To evaluate the role of Phyllanthus amarus in eradication of the virus in hepatitis B carriers. METHODS Phyllanthus amarus was administered to 30 asymptomatic carriers of hepatitis B surface antigen (HBsAg) in a dosage of 250 to 500 mg thrice d...
متن کاملEffect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
In a preliminary study, carriers of hepatitis B virus were treated with a preparation of the plant Phyllanthus amarus for 30 days. 22 of 37 (59%) treated patients had lost hepatitis B surface antigen when tested 15-20 days after the end of the treatment compared with only 1 of 23 (4%) placebo-treated controls. Some subjects have been followed for up to 9 months. In no case has the surface antig...
متن کاملHepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran
Objective(s) The aim of this study was to characterize the hepatitis B virus surface protein genotypes and sequence variations among hepatitis B virus surface antigen (HBsAg) positive chronic patients in Hormozgan province, south of Iran. Materials and Methods A total of 8 patients enrolled in this study. The surface gene was amplified and directly sequenced. Genotypes and nucleotide/amino a...
متن کاملIncidence of Hepatitis B virus Surface Antigen (HBsAg) Mutations in Naïve Treated of Chronic Carriers from Tehran Metropolis, Iran
Abstract Background: Naturally occurred hepatitis B virus (HBV) with surface mutations in a variety of chronic hepatitis B (CHB) patients who have received no vaccine or HBIG bearing substitutions in surface protein, have been reported. Objectives: Current knowledge concerning the prevalence of these naturally occurring surface antigen mutations among Iranian carriers is limited. Patients and M...
متن کاملFrequency of YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines
Abstract Background: Investigators were suspicious of tyrosine-methionine-aspartate-aspartate (YMDD) mutations occurred only in patients who were treated by lamivudine. However, YMDD mutations of hepatitis B virus gene (HBV DNA) in patients with chronic hepatitis B (CHB) untreated with antiviral medicines was reported in some studies. The aim of this study was to evaluate YMDD mutations in Ira...
متن کامل